02 Services / Products

Clinical Trials

  • Interventional and non interventional studies

    RIPH1, RIPH2, RIPH3
    Early Access (EAP), Compassionate Access (AAC)
    and Compassionate Use Program
    Early Access Program reform of July 1st

  • Drugs

    All clinical phases
    Many indications including oncology, neurology…
    CAR-T cell, Innovative Medicines…

  • Medical devices

    Study management to demonstrate safety
    and performance of theMD for EC marking
    ISO 14155
    Post-marketing study MDR 2017/745/EU

  • Dermo-cosmetics

    Class I to III
    Post-marketing and non-interventional study
    Collaboration with sites of excellence

  • Nutrition

    Health risk assessment and level of tolerance or allergy
    Post-registration study for foods for medical purposes
    Health claims

+2000

projects completed

+1000

Monitoring Visits/year

+1700

Home Nurse visits/year

+1000

Site support visits/year